Skin Microbiome Variation: Indicator or Risk Factor for Squamous Cell Carcinoma?
The skin microbiome may serve as biomarker for skin cancer progression.
The skin microbiome may serve as biomarker for skin cancer progression.
Researchers sought to investigate the connection between immune checkpoint inhibitors (ICIs) and immune- and autoimmune-related adverse events in older patients diagnosed with melanoma.
Researchers assessed the frequency and severity of cognitive impairments over time and specifically 1 year after hospitalization in patients who contracted COVID-19.